Astalon Pharma Private Limited

Astalon Pharma Private Limited - pharma in Chandigarh, India. Directors, charges & compliance details.
CIN U24232CH2009PTC031878 Incorporated 19 November 2009 ROC Chandigarh HQ Chandigarh, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2016
₹1.39 Cr
▼ 40% YoY
Net profit · FY 2016
₹39,664
Net margin 0.3%
EBITDA · FY 2016
₹4.71 Lakh
EBITDA margin 3.4%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹1.8 Lakh
Issued & subscribed
Open charges
₹35 Lakh
Secured borrowings
Company age
17 yrs
Est. 2009
Directors on board
2
As per MCA filings

About Astalon Pharma Private Limited

Data last updated:

Astalon Pharma Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 November 2009 and has been in existence for over 17 years.

The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2009PTC031878. The company has 1 GST registration on record, which is no longer active.

The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1.8 Lakh. It is led by directors Neelam Rani and Krishan Gopal.

Its last annual general meeting (AGM) was held on 30 September 2016, and its latest financial statements are for the year ended 31 March 2016. The registered office is at S.C.F. 439 Ist Floor Motor Market Manimajra, Chandigarh, India – 160101.

As per the financials filed for FY 2016, the company reported a revenue of ₹1.39 Cr, a decline of 40% compared to the previous year. For the same year it recorded a net profit of ₹39,664 (net margin 0.3%) and EBITDA of ₹4.71 Lakh (EBITDA margin 3.4%).

As per MCA filings, the company has open charges of ₹35 Lakh on record. Court records list 41 cases involving the company, including 5 filed by the company and 25 filed against it; 5 cases are pending.

The current compliance status is marked as active non-compliant by the Registrar of Companies.

Company Details of Astalon Pharma Private Limited
CIN U24232CH2009PTC031878
Registration Number 031878
Incorporation Date 19 November 2009
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2016
Date of Balance Sheet 31 March 2016
Compliance Status Active Non-Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    S.C.F. 439 Ist Floor Motor Market Manimajra, Chandigarh, India – 160101
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Astalon Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Astalon Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Astalon Pharma Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Astalon Pharma Private Limited

The main business activity of Astalon Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Astalon Pharma Private Limited FY 2016 filings available

Astalon Pharma Private Limited reported revenue of ₹1.39 Cr (down 40% YoY) for FY 2016.

Revenue · FY 2016
₹1.39 Cr ▼ 40%
Net profit · FY 2016
₹39,664 margin 0.3%
EBITDA · FY 2016
₹4.71 Lakh margin 3.4%

Compounded Annual Growth Rate (CAGR) of Astalon Pharma Private Limited

Revenue CAGR growth
1 year
▼ 40%
EBITDA CAGR growth
1 year
▼ 59%

Revenue fell 40% in the latest year. EBITDA fell 59% in the latest year. All are worked out from the filed statements.

Financial Statement Summary of Astalon Pharma Private Limited

MetricsFY 2015-16FY 2014-15
Profit and Loss Statement
Revenue from Operations••••••••
Other Income••••••••
Total Revenue••••••••
Cost of Materials Consumed••••••••
Employee Benefit Expense••••••••
Finance Costs••••••••
Depreciation and Amortisation••••••••
Other Expenses••••••••
Total Expenses••••••••
EBITDA₹4.71 Lakh••••
Profit Before Tax••••••••
Tax Expense••••••••
Net Profit (PAT)₹39,664••••
Balance Sheet
Share Capital••••••••
Reserves and Surplus••••••••
Net Worth (Total Equity)••••••••
Long-term Borrowings••••••••
Short-term Borrowings••••••••
Trade Payables••••••••
Total Liabilities••••••••
Fixed Assets••••••••
Investments••••••••
Inventories••••••••
Trade Receivables••••••••
Cash and Bank Balance••••••••
Total Assets••••••••

Financial Ratios of Astalon Pharma Private Limited

MetricsFY 2015-16FY 2014-15
Profitability
EBITDA Margin3.4%••••
Net Profit Margin0.3%••••
Return on Equity (ROE)••••••••
Return on Capital Employed (ROCE)••••••••
Return on Assets (ROA)••••••••
Liquidity and Debt
Current Ratio••••••••
Quick Ratio••••••••
Debt-to-Equity Ratio••••••••
Interest Coverage Ratio••••••••
Efficiency and Growth
Asset Turnover••••••••
Receivable Days••••••••
Payable Days••••••••
Inventory Days••••••••
Revenue Growth••••••••
Net Profit Growth••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Astalon Pharma are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Astalon Pharma Private Limited

Astalon Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Oberlin Healthcare Private Limited₹1.4 Cr (FY 2024)••••••••24.0%••••Mumbai, Maharashtra, India
Magine Pharmaceuticals Private Limited₹1.4 Cr (FY 2025)••••••••-1.0%••••Aurangabad, Maharashtra, India
Speedmed Pharma Private Limited₹1.4 Cr (FY 2024)••••••••95.0%••••Hyderabad, Telangana, India
Cureford Healthcare Private Limited₹1.39 Cr (FY 2023)••••••••-39.0%••••Rudrapur, Uttarakhand, India
Vibrant Pharmacuticals Private Limited₹1.39 Cr (FY 2025)••••••••16.0%••••Vadodara, Gujarat, India
Astalon Pharma Private Limited this company₹1.39 Cr (FY 2016)••••••••-40.0%••••Chandigarh, India
Euro Formulations Private Limited₹1.39 Cr (FY 2016)••••••••20229.0%••••Bhind, Madhya Pradesh, India
Credit Pharmaceuticals Private Limited₹1.39 Cr (FY 2018)••••••••-2.0%••••Delhi, India
Alixar Healthcare Private Limited₹1.39 Cr (FY 2024)••••••••37.0%••••Bhopal, Madhya Pradesh, India
Betlife Formulations Private Limited₹1.39 Cr (FY 2025)••••••••-11.0%••••Chennai, Tamil Nadu, India
Chromatogen Analytical Solutions (OPC) Private Limited₹1.39 Cr (FY 2025)••••••••18.0%••••Mysore, Karnataka, India

Peers are the five companies nearest above and the five nearest below Astalon Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Board of Directors of Astalon Pharma Private Limited

Astalon Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Neelam RaniDirector01 Mar 201214 Years 7 MonthsCurrent
Krishan GopalDirector19 Nov 200916 Years 10 MonthsCurrent

Charges & Borrowings of Astalon Pharma Private Limited

Open charges
₹35 Lakh
Satisfied charges
None
Breakdown by lending institutions
Icici Bank Ltd₹0.35 Cr
Latest charge details
DateLenderAmountStatus
05 Jan 2012Icici Bank Ltd₹35 LakhOpen

Total charge records: 1 View all charges

Employees and EPFO Compliance at Astalon Pharma Private Limited

Employment history and EPFO contributions of people linked to Astalon Pharma.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Astalon Pharma Private Limited

Astalon Pharma Private Limited has 5 board changes on record since 2009: 2 appointments and 3 cessations. The latest: Gopal Krishan Pathak ceased to be Director on 05 Dec 2012.

AGM
Astalon Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2016 as per latest MCA records.
Filing
Astalon Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Chandigarh.
Charges
A charge with Icici Bank Ltd of Rs. 35.00 Lakh registered on 05 Jan 2012 with Charge ID 10391832 was modified on 13 Feb 2013.
Ceased
Gopal Krishan Pathak ceased to be Director.
Ceased
Neelam Rani ceased to be Additional Director.
Appointed
Neelam Rani was appointed as Director.
Charges
A charge with Icici Bank Ltd amounted to Rs. 35.00 Lakh with Charge ID 10391832 was registered on 05 Jan 2012.
Ceased
Poonam Gupta ceased to be Director.
Appointed
Krishan Gopal was appointed as Director.
Incorporation
19 Nov 2009
Astalon Pharma Private Limited was registered on 19 Nov 2009 with Roc Chandigarh & aged 16 years 10 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Astalon Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Astalon Pharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Astalon Pharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Astalon Pharma Private Limited

Astalon Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Astalon Pharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Astalon Pharma Private Limited

Astalon Pharma is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 November 2009 (17+ years old) and is registered under CIN U24232CH2009PTC031878.

Astalon Pharma reported revenue of ₹1.39 Cr for FY 2016 (down 40% YoY).

Astalon Pharma has 2 current directors:

Astalon Pharma reported a net profit of ₹39,664 (net margin 0.3%) and EBITDA of ₹4.71 Lakh (EBITDA margin 3.4%) for FY 2016, as per its filed financial statements.

No. Astalon Pharma has 1 GST registration on record and it is cancelled or inactive.

The CIN (Corporate Identification Number) of Astalon Pharma is U24232CH2009PTC031878. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Astalon Pharma has 41 court cases on record: 5 filed by the company and 25 filed against it. 5 are pending. Most are in the district courts.

Astalon Pharma was incorporated on 19 November 2009, making it 17+ years old. It is registered with the Registrar of Companies, Chandigarh.

The peers of Astalon Pharma by revenue are Oberlin Healthcare Private Limited, Magine Pharmaceuticals Private Limited, Speedmed Pharma Private Limited, Cureford Healthcare Private Limited, Vibrant Pharmacuticals Private Limited and 5 more, all in the Pharma industry (Formulations).

Gopal Krishan Pathak ceased to be Director on 05 Dec 2012. Neelam Rani ceased to be Additional Director on 20 Sep 2012. Neelam Rani was appointed as Director on 01 Mar 2012. Astalon Pharma has 5 board changes on record in total.

The registered office of Astalon Pharma is at S.C.F. 439 Ist Floor Motor Market Manimajra, Chandigarh, India – 160101.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available